Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By A.I.
SPONSOR: http://www.CertifiedMedicalPlanner.org
***
***
What’s up
- Medpace isn’t a meme stock, but it still soared 54.67% yesterday. It was all thanks to a seriously impressive beat-and-raise earnings report for the clinical researcher.
- It was also a great day for healthcare stocks: IQVIA climbed 17.92% after beating Wall Street forecasts last quarter.
- DR Horton popped 17.02% after the homebuilder crushed Q3 earnings expectations.
- It was also a great day for other homebuilders: Pultegroup rose 11.52% despite lower home closings last quarter, and management is optimistic that sales will bounce back next quarter.
- Northrop Grumman gained 9.41% after a strong quarter, including an 18% increase in international sales for the defense contractor.
What’s down
- Lockheed Martin dropped 10.81% after the legacy defense contractor revealed big losses in its classified aeronautics program.
- It wasn’t that great a day for defense contractors in general: RTX fell 1.58% after the company cut its earnings guidance.
- General Motors may have beaten earnings expectations last quarter and kept its fiscal forecast intact, but investors didn’t like to hear about the $1.1 billion in tariff costs. Shares of the automaker stumbled 8.12%
- Coca-Cola lost 0.59% after strong European sales helped the soft drink titan beat earnings estimates, but shareholders weren’t happy about weakness everywhere else.
- Equifax tumbled 8.18% thanks to disappointing guidance for the current quarter from the consumer credit company.
COMMENTS APPRECIATED
Like and Subscribe
***
***
Share this:
Filed under: "Ask-an-Advisor", CMP Program, Financial Planning, Investing, Portfolio Management | Tagged: CMP, Coca-Cola, down stocks, DR Horton, Equifax, General Motors, GM, Grumman, medpace, RTX, stock markerts, stocks, up stocks |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Leave a comment